Human Touch · Super Novo 3.0
Ready to buy
The retained reference is $11,999 current independently verified U.S. reference. Confirm installed firmware, active AI functions, tablet contents, delivery level, entry route and labor coverage rather than buying an announced capability. Confirm the current configuration, included parts, support path, return terms and the work that must be preserved before ordering.
Current market
Each line carries its own check date because price, software, specifications, and product cycle do not age at the same speed.
Confirm installed firmware, active AI functions, tablet contents, delivery level, entry route and labor coverage rather than buying an announced capability. Confirm the checkout price and package before paying.
Super Novo 3.0 is defensible for buyers who prefer its wider seat and tablet interface and can separate current DuoSync hardware from any not-yet-proven software promise.
Other paths
These are not generic competitors. Each one represents a different way to buy into the same market.
Human Touch
Human Touch
What changed
Older observations stay in the ledger when the current view changes. That lets a buyer tell the difference between an old complaint, an active issue, and a problem that was corrected.
Super Novo 3.0 was checked against its manufacturer record, the current category collection and the nearest ownership alternatives.
Each amount stays tied to its source and capture date. Conflicting prices remain visible until the seller resolves them.
Current reference priceA structured timeline will begin with the next source capture
Owner experience
Owner discussion repeatedly returns to firmware delivery, tablet workflow, dual-mechanism coordination, wider-seat fit, calf pressure, heavy delivery and support rather than specifications alone.
These are self-reported experiences from a changing mix of owners, conditions and software versions. They identify questions to test, not a failure rate. Comfort, anatomy, mobility, medical history, pressure tolerance, firmware, delivery route and service region vary materially.A bounded launch-period discussion reports showroom feel, feature balance and purchasing impressions. It does not prove shipped firmware, treatment effect or long-term reliability.
Verify the installed software at acceptance and run every intended user through stop, pause and exit; launch impressions cannot prove future firmware, durable service or health outcomes.
1 evidence recordSources
The page separates what a source states directly from what we conclude across sources.
Human Touch identifies Super Novo 3.0 as a current 291-pound DuoSync chair with an upper 3D and lower 2D mechanism, wireless tablet, fixed programs and an announced AI-generated-program branch
The independent, affiliate-disclosed 2026 comparison verifies the Super Novo 3.0 at $11,999. Delivery and software availability still require confirmation on the exact order.
Human Touch publishes setup, compatibility or service material that makes this purchase boundary explicit: The $11,999 hardware and fixed program set are current, while any announced unlimited AI-generated program or Virtual Therapist function must remain marked promised until the installed firmware and support record prove delivery. White-glove delivery and extended labor are separate. This is a powered comfort product, not a diagnosis or treatment recommendation. FDA establishment registration or device listing is not FDA approval, clearance or proof that a chair cures, treats or prevents disease. Massage-chair classification under 21 CFR 890.5660 does not support circulation, inflammation, spinal-decompression or pain-treatment promises. Body scans, heart-rate, oxygen, stress, fatigue or pressure sensors are non-diagnostic and must not guide medical care. Read the exact manual and ask a clinician before use when it directs consultation, including for an implanted device, pregnancy, recent injury or surgery, impaired sensation, bone or vascular conditions or another relevant health concern. Stop for pain, numbness, dizziness or distress. Keep children and pets away from the chair, footrest, doors and recline path; protect pinch points, use a grounded undamaged outlet, unplug before cleaning or service and enter or exit only when the mechanism is stopped. Verify only the certification mark and model actually documented by an OSHA-recognized NRTL. Roller labels such as 2D, 3D and 4D are not standardized comfort rankings, so every intended user needs a real fit and minimum-intensity trial. App, voice, profile and sensor data require a privacy, permission, update and local-control review. Delivery route, doorway, turns, floor loading, assembly, return freight, warranty labor, parts and post-warranty service are part of the purchase.
The federal classification describes powered massage devices as Class I physical-medicine devices. Classification does not turn a home chair into evidence that it diagnoses, cures or treats a condition.
Current hands-on comparison distinguishes roller architecture, track, fit, lower-body behavior, controls, warranty and price while keeping showroom comfort subjective and tied to the tested user.
FDA explains establishment registration and device listing requirements. Registration or listing does not mean FDA has approved, cleared or endorsed the establishment or device.
A bounded launch-period discussion reports showroom feel, feature balance and purchasing impressions. It does not prove shipped firmware, treatment effect or long-term reliability.
Super Novo X represents the flagship dual-mechanism connected chair branch at $15,999 current independent U.S. base reference.
Super Novo 2.0 represents the mature feature-rich human touch connected chair branch at $10,999 current independent U.S. reference.
The manufacturer record, current market collection, support material and independent category evidence were checked on August 17, 2026. The checkout package and regional support path still need verification. Owner reports are retained as bounded experience, not a reliability rate. This is a powered comfort product, not a diagnosis or treatment recommendation. FDA establishment registration or device listing is not FDA approval, clearance or proof that a chair cures, treats or prevents disease. Massage-chair classification under 21 CFR 890.5660 does not support circulation, inflammation, spinal-decompression or pain-treatment promises. Body scans, heart-rate, oxygen, stress, fatigue or pressure sensors are non-diagnostic and must not guide medical care. Read the exact manual and ask a clinician before use when it directs consultation, including for an implanted device, pregnancy, recent injury or surgery, impaired sensation, bone or vascular conditions or another relevant health concern. Stop for pain, numbness, dizziness or distress. Keep children and pets away from the chair, footrest, doors and recline path; protect pinch points, use a grounded undamaged outlet, unplug before cleaning or service and enter or exit only when the mechanism is stopped. Verify only the certification mark and model actually documented by an OSHA-recognized NRTL. Roller labels such as 2D, 3D and 4D are not standardized comfort rankings, so every intended user needs a real fit and minimum-intensity trial. App, voice, profile and sensor data require a privacy, permission, update and local-control review. Delivery route, doorway, turns, floor loading, assembly, return freight, warranty labor, parts and post-warranty service are part of the purchase. Comfort, pressure and body contact are subjective and user-specific. Marketing language about relief, recovery, therapy, circulation, inflammation, decompression, pain, posture or wellness is not retained as a medical claim. FDA registration is not approval. Only the exact certification mark, model and current NRTL directory record may be stated. Body and wellness sensors are non-diagnostic. Current software is separated from announced or promised features, especially on Super Novo 3.0.
Researching another model?